Protecting health: Active generic and biosimilar policies central to EU pharmaceutical strategy

3 March 2020

Equitable and sustainable access to medicines is a concern across […]

Impact of COVID-19 on active ingredient and medicines manufacturing and supplies in Europe

18 February 2020

The European Medicines Verification System (EMVS) celebrates 1 year of successful operation across Europe

7 February 2020

Time to modernise the EU pharmaceutical regulatory framework to deliver on access

30 January 2020

To maintain its leadership in pharmaceutical regulatory science, the EU […]

Smart Pharmacovigilance Essential for Patient Safety

29 January 2020

Medicines are developed and manufactured to help patients so, it […]

AMR life science industry 2020 report: Successes and setbacks in fighting superbugs

16 January 2020

Hanan Sboul takes over the position of IGBA Chair

7 January 2020

Better access to medicines in Bulgaria prioritised by Medicines for Europe President

16 December 2019

Christoph Stoller, the President of Medicines for Europe, led an […]

Generic & biosimilar medicines pivotal for safe, effective and affordable access to medicines in Europe

28 November 2019

The European Commission has identified the use of generic and […]

Open letter from Medicines for Europe Executive on medicines shortages

26 November 2019